Midazolam 1 mg, Psilocybine 5 mg
RAFAEL
Phase 2 small_molecule active
Quick answer
Midazolam 1 mg, Psilocybine 5 mg for Stable Ischemic Heart Disease is a Phase 2 program (small_molecule) at s.r.o. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- s.r.o.
- Indication
- Stable Ischemic Heart Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active